HSP4 triggers epithelial-mesenchymal transition and promotes motility capacities of hepatocellular carcinoma cells via activating AKT

被引:20
|
作者
Ma, Peng [1 ]
Tang, Wei-Guo [2 ,3 ]
Hu, Jin-Wu [4 ,5 ]
Hao, Ying [1 ]
Xiong, Liang-Kun [1 ]
Wang, Mao-Ming [1 ]
Liu, Hao [1 ]
Bo, Wen-Hui [1 ]
Yu, Kai-Huan [1 ]
机构
[1] Wuhan Univ, Renmin Hosp, Dept Hepatobiliary Surg, Wuhan 430060, Hubei, Peoples R China
[2] Fudan Univ, Minhang Hosp, Dept Hepatobiliary & Pancreat Surg, Shanghai, Peoples R China
[3] Inst Fudan Minhang Acad Hlth Syst, Shanghai, Peoples R China
[4] Fudan Univ, Zhongshan Hosp, Dept Liver Surg & Transplantat, Shanghai, Peoples R China
[5] Fudan Univ, Key Lab Carcinogenesis & Canc Invas, Minist Educ, Shanghai, Peoples R China
基金
中国国家自然科学基金;
关键词
AKT pathway; heat shock factor; hepatocellular carcinoma cell; tumour behaviour; FREE SURVIVAL; HSF4; TRANSCRIPTION;
D O I
10.1111/liv.14410
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background and Aims Heat shock factor (HSF4) plays a vital role in carcinogenesis and tumour progression. However, its clinical significance implications in hepatocellular carcinoma (HCC) remained elusive. Methods RT-PCR and western blot were used to detect the HSF4 expression levels in HCC cells and tissues. Immunohistochemistry staining was performed on a tissue microarray containing 104 HCC patients received radical resection. In vitro effects of HSF4 on proliferation, migration and invasion were determined by colony formation and transwell assays in HCCLM3, Huh7, MHCC97L and SMMC7721 cells. Epithelial-mesenchymal transition (EMT) was identified by RT-PCR, WB and immunofluorescence in HCCLM3 and MHCC97L cells. AKT pathway activation was detected by WB and dual luciferase report system in HCCLM3 and MHCC97L cells. Results HSF4 expression was higher in primary HCC tissues derived from recurrent patients, and positively correlated with invasiveness potentials of cell lines. Clinically, patients with high HSF4 expression had significant poorer prognosis. In vitro experiments showed HSF4 silencing inhibited HCC cell proliferation, migration and invasion, whereas HSF4 overexpression had inverse effects. Moreover, silence of HSF4 induced an epithelial-like phenotype, whereas the overexpression of HSF4 resulted in a mesenchymal-like phenotype in HCC by activating AKT pathway. Further experiments showed that HSF4 could activate AKT pathway in a hypoxia-inducible factor-1 alpha (HIF-1 alpha) dependent, but transforming growth factor-beta (TGF-beta) independent manner. Conclusions HSF4 is upregulated in HCC, resulting in greater proliferation, migration and invasion capacities. Moreover, high HSF4 expression is a promising predictive indicator of poor outcome after radical resection. HSF4 may promote aggressive tumour behaviour by enhancing EMT through activating AKT pathway in a HIF1 alpha-dependent manner.
引用
收藏
页码:1211 / 1223
页数:13
相关论文
共 50 条
  • [1] SNRPC promotes hepatocellular carcinoma cell motility by inducing epithelial-mesenchymal transition
    Zhang, Yuanping
    Qiu, Jiliang
    Zuo, Dinglan
    Yuan, Yichuan
    Qiu, Yuxiong
    Qiao, Liang
    He, Wei
    Li, Binkui
    Yuan, Yunfei
    FEBS OPEN BIO, 2021, 11 (06): : 1757 - 1770
  • [2] JARID1B promotes metastasis and epithelial-mesenchymal transition via PTEN/AKT signaling in hepatocellular carcinoma cells
    Tang, Bo
    Qi, Guangying
    Tang, Fang
    Yuan, Shengguang
    Wang, Zhenran
    Liang, Xingsi
    Li, Bo
    Yu, Shuiping
    Liu, Jie
    Huang, Qi
    Wei, Yangchao
    Zhai, Run
    Lei, Biao
    Yu, Hongping
    Jiao, Xingyuan
    He, Songqing
    ONCOTARGET, 2015, 6 (14) : 12723 - 12739
  • [3] Galectin-1 Triggers Epithelial-Mesenchymal Transition in Human Hepatocellular Carcinoma Cells
    Bacigalupo, Maria L.
    Manzi, Malena
    Espelt, Maria V.
    Gentilini, Lucas D.
    Compagno, Daniel
    Laderach, Diego J.
    Wolfenstein-Todel, Carlota
    Rabinovich, Gabriel A.
    Troncoso, Maria F.
    JOURNAL OF CELLULAR PHYSIOLOGY, 2015, 230 (06) : 1298 - 1309
  • [4] BVES Inhibition Triggers Epithelial-Mesenchymal Transition in Human Hepatocellular Carcinoma
    Han, Ping
    Fu, Yu
    Luo, Min
    He, Jiayi
    Liu, Jingmei
    Liao, Jiazhi
    Tian, Dean
    Yan, Wei
    DIGESTIVE DISEASES AND SCIENCES, 2014, 59 (05) : 992 - 1000
  • [5] BVES Inhibition Triggers Epithelial-Mesenchymal Transition in Human Hepatocellular Carcinoma
    Ping Han
    Yu Fu
    Min Luo
    Jiayi He
    Jingmei Liu
    Jiazhi Liao
    Dean Tian
    Wei Yan
    Digestive Diseases and Sciences, 2014, 59 : 992 - 1000
  • [6] HNRNPAB Induces Epithelial-Mesenchymal Transition and Promotes Metastasis of Hepatocellular Carcinoma by Transcriptionally Activating SNAIL
    Zhou, Zheng-Jun
    Dai, Zhi
    Zhou, Shao-Lai
    Hu, Zhi-Qiang
    Chen, Qing
    Zhao, Yi-Ming
    Shi, Ying-Hong
    Gao, Qiang
    Wu, Wei-Zhong
    Qiu, Shuang-Jian
    Zhou, Jian
    Fan, Jia
    CANCER RESEARCH, 2014, 74 (10) : 2750 - 2762
  • [7] CRP-1 promotes the malignant behavior of hepatocellular carcinoma cells via activating epithelial-mesenchymal transition and Wnt/β-catenin signaling
    Lei, Shixiong
    Du, Xilin
    Tan, Kai
    He, Xiaojun
    Zhu, Yejing
    Zhao, Shoujie
    Yang, Zhenyu
    Dou, Gang
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2023, 26 (01)
  • [8] Epithelial-mesenchymal transition in hepatocellular carcinoma
    van Zijl, Franziska
    Zulehner, Gudrun
    Petz, Michaela
    Schneller, Doris
    Kornauth, Christoph
    Hau, Mara
    Machat, Georg
    Grubinger, Markus
    Huber, Heidemarie
    Mikulits, Wolfgang
    FUTURE ONCOLOGY, 2009, 5 (08) : 1169 - +
  • [9] Insufficient radiofrequency ablation promotes epithelial-mesenchymal transition of hepatocellular carcinoma cells through Akt and ERK signaling pathways
    Shuying Dong
    Jian Kong
    Fandong Kong
    Jinge Kong
    Jun Gao
    Shan Ke
    Shaohong Wang
    Xuemei Ding
    Wenbing Sun
    Lemin Zheng
    Journal of Translational Medicine, 11
  • [10] Insufficient radiofrequency ablation promotes epithelial-mesenchymal transition of hepatocellular carcinoma cells through Akt and ERK signaling pathways
    Dong, Shuying
    Kong, Jian
    Kong, Fandong
    Kong, Jinge
    Gao, Jun
    Ke, Shan
    Wang, Shaohong
    Ding, Xuemei
    Sun, Wenbing
    Zheng, Lemin
    JOURNAL OF TRANSLATIONAL MEDICINE, 2013, 11